Archive: 04/08/2014

Weakness of leukaemic stem cells discovered

Despite improved therapy, only one out of every two adult patients survive acute myeloid leukaemia (AML). The mean survival time for this disease, which predominantly occurs in the elderly, is less than a year for patients ...

page 7 from 10